By successfully completing the acquisition of Hahn Healthcare, an Australian medical engagement company, DKSH continues its strategy to offer wide market coverage across Asia Pacific and its focus on value-added services and sales force outsourcing.
Media release
Zurich, Switzerland, July 1, 2021 – DKSH has successfully completed the acquisition of Hahn Healthcare, a leading healthcare professional engagement company in Australia.
Stefan P. Butz, CEO of DKSH, said: "After Bosung, Medworkz and SACOA, Hahn Healthcare is the fourth acquisition that we have successfully closed this year. It is an important milestone in our strategic journey and helps us to ensure wide market coverage and the ability to offer additional value-added services. We are happy to have Hahn Healthcare onboard and look forward to jointly delivering growth for our clients.”
For further information, please contact:
DKSH Holding Ltd.
Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com
Demet Biçer
Manager, Group Media Relations
Phone +41 44 386 7217
demet.bicer@dksh.com
DKSH Business Unit Healthcare
Sheena Flannery
Director, Group Communications
Phone +66 2 220 9739
sheena.flannery@dksh.com
About DKSH
At DKSH, our purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,970 specialists, the Business Unit generated net sales of CHF 5.4 billion in 2020. www.dksh.com/hec